In a First, a Cannabis-Derived Pharma Product Is Descheduled in the US

Cannabis Wire
By Nushin RashidianApr 6, 2020, 6:08 pm244 pts
The story of GW Pharmaceuticals in the United States is one of firsts. In 2018, the British company became the first to obtain approval from the US Food and Drug Administration for a product derived directly from cannabis plants. That same product, Epidiolex, a CBD formula for patients with rare forms of…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Legal Pot Delivery 101: A Beginner’s Guide to Cannabis at Your Door 68

Lawmakers urge Trump to act on cannabis 65

Grön, Head Change Debut Exclusive Solventless Edibles in Missouri 35

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.